Member Login
  1. Stocks
    2. /
  2. Bausch Health Companies Inc. (NYSE: BHC)
    3. /

NYSE:BHC (Bausch Health Companies Inc.)

About BHC

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Bausch Health Companies Inc. (NYSE: BHC) Latest News

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: 3 More Game-Changing Updates

    | Benjamin Sinclair

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) likes to keep investors guessing.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Is it a Turnaround Candidate or Is More Trouble Ahead?

    | Demetris Afxentiou

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is both loved and loathed by investors, and recent events might be the start of…

    Read more »

    The Motley Fool
    Investing

    Was Andrew Left Right About Valeant Pharmaceuticals Intl Inc.?

    | Benjamin Sinclair

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) may have some explaining to do.

    Read more »

    The Motley Fool
    Investing

    Why Valeant Pharmaceuticals Intl Inc. Shares Are Down 19% in 2 Days

    | Benjamin Sinclair

    Analyst David Maris is not a fan of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX).

    Read more »

    The Motley Fool
    Investing

    Is Valeant Pharmaceuticals Intl Inc. Worth the Risk?

    | Demetris Afxentiou

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has had a devastating past few months, and while the chain of bad news may…

    Read more »

    The Motley Fool
    Investing

    3 Reasons Valeant Pharmaceuticals Intl Inc. Is in for a Rough Ride on Thursday

    | Benjamin Sinclair

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is set to testify before Congress. It won't be fun for the company.

    Read more »

    The Motley Fool
    Investing

    Hillary Clinton Is Targeting Valeant Pharmaceuticals Intl Inc.

    | Benjamin Sinclair

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has a number of targets on its back.

    Read more »

    The Motley Fool
    Investing

    More Bad News for Valeant Pharmaceuticals Intl Inc.

    | Benjamin Sinclair

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) will be subject to even more public scrutiny.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: The Plan for 2016

    | Benjamin Sinclair

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) will look very different in 2016.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: The Good News and the Bad News

    | Benjamin Sinclair

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is in the midst of a very big week.

    Read more »

    The Motley Fool
    Investing

    This Week Could Make or Break Valeant Pharmaceuticals Intl Inc.

    | Benjamin Sinclair

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) will host its investor day on Wednesday. The stakes couldn't be higher.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: We Are Still in the Early Innings

    | Benjamin Sinclair

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is not even close to the end of the tunnel.

    Read more »